期刊文献+

帕瑞昔布复合丙泊酚用于人工流产术的临床观察

Parecoxib and Propofol for the clinical observation of induced abortion
下载PDF
导出
摘要 目的观察帕瑞昔布复合丙泊酚用于人工流产术的临床麻醉效果及安全性。方法选择180例体健、自愿人工流产的患者,随机分为A、B两组。采用全凭静脉麻醉方法,A组:先静脉注射帕瑞昔布20 mg,7 min后再静脉注射丙泊酚2 mg/kg,B组:静脉注射瑞芬太尼1μg/kg,2 min后再静脉注射丙泊酚2 mg/kg,术中出现较强体动时追加丙泊酚。记录两组术前、术中、术后的心率(HR)、收缩压(SBP)、呼吸频率(RR)、血氧饱和度(SpO2)值及术后不良反应。结果术中HR、SBP、RR、SpO2,B组与A比较,差异有统计学意义(P<0.05)。B组术中HR、SBP、RR、SpO2与术前比较,差异有高度统计学意义(P<0.01)。结论帕瑞昔布复合丙泊酚用于人工流产临床麻醉效果安全有效,能为患者提供全程镇痛。 Objective To observe clinical efficacy and safety of Parecoxib and Propofol for induced abortion anesthesia.Methods 180 cases of physical health,voluntary abortion were randomly divided into two groups,group A and group B,used of total intravenous anesthesia,group A: first intravenous injection of Parecoxib 20 mg,7 min after intravenous injection of Propofol 2 mg/kg,group B: Intravenous injection of Remifentanil 1 μg/kg,2 min after intravenous injection of propofol 2 mg/kg,stronger body of moving had an additional Propofol.Recorded BP HR,RR,SpO2 in preoperative,operation in,postoperative and adverse reactions in postoperative.Results Intraoperative HR,SBP,RR,SpO2,difference between group A and group B was statistically significant(P 0.05).Patients in the HR,SBP,RR,SpO2 in group B in operation compared with the preoperative,the difference was highly statistically significant(P 0.01).Conclusion Parecoxib and Propofol anesthesia is effective for patients of induced abortion safe and can provide full analgesia.
出处 《中国医药导报》 CAS 2012年第4期42-43,共2页 China Medical Herald
关键词 帕瑞昔布 丙泊酚 人工流产 瑞芬太尼 Parecoxib Propofol Abortion Remifentanil
  • 相关文献

参考文献8

二级参考文献28

  • 1曹建国,杭燕南.新一代非甾体类抗炎药环氧化酶-2抑制剂[J].临床麻醉学杂志,2001,17(5):272-274. 被引量:2
  • 2郑清民,李师阳,肖全胜,姚伟瑜,房小斌.雷米芬太尼和丙泊酚复合麻醉用于人工流产的观察[J].临床麻醉学杂志,2005,21(1):64-64. 被引量:22
  • 3Hitzenberger G, Radhofer-Wehe S, Takacs F, et al. Pharma cokinetics of lornoxicam in man. Postgrad Med J, 1990,66 : 22-27.
  • 4Kehlet H. Surgical Stress: the role of pain analgesia. Br J Anaesth, 1989,63: 189.
  • 5庄心良,曾因明,陈伯銮,主编.现代麻醉学.第3版.北京:人民卫生出版社,2004:2610-2612.
  • 6Desjardins PJ, Grossman EH, Kuss ME, et al. The injectable cyclooxygenase- 2 specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively. Anesth Analg,2001,93 (3) :721 - 727.
  • 7Tang J, Li S, White PF, et al. Effect of parecoxib, a novel intravenous cyclooxygenase type- 2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology 2002, 96 ( 6 ) : 1305 - 1309.
  • 8White RH, Henderson MC. Risk factors for venous thromboembolism after total hip and knee replacement surgery. Current Opinion in Pulmonary Medicine,2002,8(5 ) :365 - 371.
  • 9Maheshwari AV, Blum YC, Shekhar L, et al. Multimodal pain management after total hip and knee arthroplasty at the Ranawat orthopaedic center. Clin Orthop Relat Res,2009,467(6) :1418 -1423.
  • 10Akritopoulos P, Papaioannidou P, Hatzokos I, et al. Parecoxib has non - significant longterm effects on bone healing in rats when ad- ministered for a short period after fracture. Arch Orthop Trauma Surg, 2009,129(10) : 1427 - 1432.

共引文献312

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部